Pleurodesis in recurrent pleural effusions: A randomized comparison of a classical and a currently popular drug

Lung Cancer

Volumn 43, Issue 3, 2004, Pages 323-328

  Ukale, Valiant ^a   Agrenius, Veronica ^a   Hillerdal, Gunnar ^a   Mohlkert, Dag ^a   Widström, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Pleural effusion; Pleurodesis; Quinacrine; Randomized study; Talc; Thoracoscopy

Indexed keywords

MEPACRINE; TALC;

AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION; LIQUID; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PAIN; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; SIDE EFFECT; THORACOSCOPY; THORAX DRAINAGE; THORAX RADIOGRAPHY; TUBE;

EID: 1242351331     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.09.014     Document Type: Article

References (18)

1. Andrews C.O., Gora M.L. Pleural effusions: pathophysiology and management. Ann. Pharmacother. 28:1994;894-902.
2. Light R.W., Vargas F.S. Pleural sclerosis for the treatment of pneumothorax and pleural effusion. Lung. 175:1997;213-223.
3. Walker-Renard P.B., Vaughan L.M., Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann. Intern. Med. 120:1994;56-64.
4. Antony V.B., Loddenkemper R., Astoul P., Boutin C., Goldstraw P., Hott J.et al. Management of malignant pleural effusions. Eur. Respir. J. 18:2001;402-419.
5. Glazer M., Berkman N., Lafair J.S., Kramer M.R. Successful talc slurry pleurodesis in patients with non-malignant pleural effusion. Report of 16 cases and review of the literature. Chest. 117:2000;1404-1409.
6. Agrenius V., Ukale V., Widström O., Källenius G., Svenson S.B. Quinacrine-induced pleural inflammation in malignant pleurisy: Relation between drainage time of pleural fluid and local interleukin-1 levels. Respiration. 60:1993;366-372.
7. Prevost A., Costa B., Elamarti R., Nazeyrollas P., Mallet F., Yazbek G. et al. Long-term effect and tolerance of talc slurry for control of malignant pleural effusions. Oncol. Rep. 8:2001;1327-1331.
8. Kennedy L., Sahn S.A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 106:1994;1215-1222.
9. Sahn S.A. Talc should be used for pleurodesis. Am. J. Respir. Crit. Care Med. 162:2000;2023-2024.
10. Blanchard CG, Ruckdeschel JC. Quality of life. In: Roth JA, Ruckdeschel JC, Weisenburger TH, editors. Thoracic oncology. Philadelphia: Saunders; 1989. p. 681-6.
11. Light R.W. Talc should not be used for pleurodesis. Am. J. Respir. Crit. Care Med. 162:2000;2024-2026.
12. Milanez de Campos J.R., Vargas F.S., Werebe E.C., Cardoso P., Teixeira L.R., Jatene F.B.et al. Thoracoscopy talc poudrage. A 15-years experience. Chest. 119:2001;801-806.
13. Ferrer J., Villarino M.A., Tura J.M., Traveria A., Light R.W. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest. 119:2001;1901-1905.
14. Stiksa G., Korsgaard R., Simonsson B.G. Treatment of recurrent pleural effusion by pleurodesis with Quinacrine. Scand. J. Respir. Dis. 60:1979;197-205.
15. Boniface E., Guérin J.C. Intérét du talcage par thoracoscopie dans le traitement symptomatique des pléuresies récidivantes. Rev. Mal. Respir. (Paris). 6:1989;133-140.
16. Yim A.P.C., Chan A.T.C., Lee T.W., Wan I.Y.P., Ho J.K.S. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann. Thorac. Surg. 62:1996;1655-1658.
17. Heffner J.E., Nietert P.J., Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Chest. 117:2000;87-95.
18. Aelony Y., King R.R., Boutin C. Thoracoscopic talc poudrage in malignant pleural effusions. Effective pleurodesis despite low pleural pH. Chest. 113:1998;1007-1012.